Literature DB >> 1554930

Naloxone-associated patient violence: an overlooked toxicity?

G M Gaddis1, W A Watson.   

Abstract

OBJECTIVE: To report two cases of a previously unreported adverse effect, violent patient behavior, after the reversal of sedation by intravenous naloxone.
DESIGN: Case report. PATIENTS/
INTERVENTIONS: Responses of two individuals who had reversal of sedation by intravenous naloxone are compared.
RESULTS: Placement of patient restraints before the administration of intravenous naloxone to obtunded or unconscious patients can make an important contribution to the safety of patients, healthcare personnel, and public safety personnel, as illustrated by the violent reaction of one unrestrained patient after naloxone administration.
CONCLUSIONS: Patient restraint should be considered before naloxone administration to protect the patient and healthcare workers. In the prehospital setting, limiting the use of naloxone to patients with decreased mental status and respiratory depression would decrease the likelihood of naloxone-induced violent behavior.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1554930     DOI: 10.1177/106002809202600211

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  7 in total

Review 1.  Naloxone in opioid poisoning: walking the tightrope.

Authors:  S F J Clarke; P I Dargan; A L Jones
Journal:  Emerg Med J       Date:  2005-09       Impact factor: 2.740

Review 2.  Naloxone dosage for opioid reversal: current evidence and clinical implications.

Authors:  Rachael Rzasa Lynn; J L Galinkin
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

3.  Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative study.

Authors:  Stephen Parkin; Joanne Neale; Caral Brown; Aimee N C Campbell; Felipe Castillo; Jermaine D Jones; John Strang; Sandra D Comer
Journal:  Int J Drug Policy       Date:  2020-04-15

4.  Factors associated with withdrawal symptoms and anger among people resuscitated from an opioid overdose by take-home naloxone: Exploratory mixed methods analysis.

Authors:  Joanne Neale; Nicola J Kalk; Stephen Parkin; Caral Brown; Laura Brandt; Aimee N C Campbell; Felipe Castillo; Jermaine D Jones; John Strang; Sandra D Comer
Journal:  J Subst Abuse Treat       Date:  2020-08-05

5.  Naloxone interventions in opioid overdoses: a systematic review protocol.

Authors:  Lindsay Victoria Shaw; Jessica Moe; Roy Purssell; Jane A Buxton; Jesse Godwin; Mary M Doyle-Waters; Penelope M A Brasher; Jeffrey P Hau; Jason Curran; Corinne M Hohl
Journal:  Syst Rev       Date:  2019-06-11

6.  More than just availability: Who has access and who administers take-home naloxone in Baltimore, MD.

Authors:  Lauren Dayton; Rachel E Gicquelais; Karin Tobin; Melissa Davey-Rothwell; Oluwaseun Falade-Nwulia; Xiangrong Kong; Michael Fingerhood; Abenaa A Jones; Carl Latkin
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.752

7.  Use of nebulized naloxone to reverse methadone overdose - A case report and review of literature.

Authors:  Muhammad Sameed; Heidi Teague
Journal:  J Community Hosp Intern Med Perspect       Date:  2019-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.